Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of apoB100 from human HepG2 cells

Journal of Nutrition

Volumn 133, Issue 3, 2003, Pages 700-706

  Pal, Sebely ^a   Ho, Nerissa ^a   Santos, Carlos ^a   Dubois, Paul ^a   Mamo, John ^a   Croft, Kevin ^b   Allister, Emma ^a  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

ApoB100; Cholesterol; LDL receptor; Lipoproteins; Red wine polyphenolics

Indexed keywords

ALCOHOL DERIVATIVE; APOLIPOPROTEIN B100; ATORVASTATIN; CATECHIN; EPICATECHIN; ESTROGEN; FLAVONOID; GALLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PHENOL DERIVATIVE; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL; STILBENE;

ALCOHOLIC BEVERAGE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG PROTEIN BINDING; EPIDEMIOLOGICAL DATA; ESTROGEN ACTIVITY; FOOD COMPOSITION; FOOD INTAKE; GENE EXPRESSION REGULATION; HEART PROTECTION; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RED WINE; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; WINE;

EID: 0037369915     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.3.700     Document Type: Article

References (47)

1. Keys, A., Menotti, A., Karvonen, M. J., Aravanis, C., Blackburn, H., Buzina, R., Djordjevic, B. S., Dontas, A. S., Fidanza, F. & Keys, M. H. (1986) The diet and 15-year death rate in the Seven Countries Study. Am. J. Epidemiol. 124: 903-915.
2. De Lorgeril, M., Salen, P., Martin, J. L., Mamelle, N., Monjaud, I., Touboul, P. & Delaye, J. (1996) Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutrients. J. Am. Coll. Cardiol. 28: 1103-1108.
3. Hertog, M.G.L., Fesken, E.J.M., Holiman, P.C.H., Katan, M. B. & Kromhout, D. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly study. Lancet 342: 1007-1011.
4. Hertog, M. G., Kromhout, D., Aravanis, C., Blackburn, H., Buzina, R., Fidanza, F., Giampaoli, S., Jansen, A., Menotti, A. & Nedeljkovic, S. (1995) Flavonoid intake and long-term risk of cardiovascular disease and cancer in the seven countries study. Arch. Intern. Med. 155: 381-386.
5. Goldberg, D. M., Hahn, S. & Parkes, J. (1995) Beyond alcohol: beverage consumption and cardiovascular mortality. Clin. Chim. Acta 2237: 155-187.
6. Criqui, M. H. & Ringel, B. L. (1994) Does diet or alcohol explain the French paradox? Lancet 344: 1719-1723.
7. Renaud, S. (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339: 1523-1526.
8. Fremont, L. (2000) Biological effects of resveratrol. Life Sci. 66: 663-673.
9. Goldberg, D. M., Garovic-Kocic, V., Diamandis, E. P. & Pace-Ascia, F. (1996) Wine: does color count? Clin. Chim. Acta 246: 183-193.
10. Valsa, A. K., Ushakumari, B. & Vijayalakshmi, N. P. (1995) Effect of catechin on lipid metabolism. J. Clin. Biol. Nutr. 19: 175-182.
11. Xu, R. P., Yokoyama, W. H., Irving, D., Rein, D., Walzem, R. L. & German, J. B. (1998) Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters. Atherosclerosis 137: 29-36.
12. Vinson, J. A., Teufel, K. & Wu, N. (2001) Red wine, dealcoholised red wine, and especially grape juice, inhibit atherosclerosis in hamster model. Atherosclerosis 156: 67-72.
13. Simionescu, N. & Simionescu, M. (1991) Cellular interactions of lipoproteins with the vascular endothelium: endocytosis and transcytosis. Targeted Diagn. Ther. 5: 45-97.
14. Packard, C. J., Demant, T., Stewart, J. P., Bedford, D., Caslake, M. J., Schwertfeger, G., Bedynek, A., Shepherd, J. & Seidel, D. (2000) Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J. Lipid Res. 23: 41305-41317.
15. Endo, A. (1992) The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33: 1569-1582.
16. Brown, M. S. & Goldstein, J. L. (1998) The LDL receptor concept: clinical and therapeutic implications. In: Bile Acids and Atherosclerosis, vol. 15 (Grundy. S., ed.), pp. 85-93. Raven Press, New York, NY.
17. Klurfeild, D. & Kritchevsky, D. M. (1981) Differential effects of alcoholic beverages on experimental atherosclerosis in rabbits. Exp. Mol. Pathol. 34: 62-71.
18. Hayek, T., Fulrman, B., Vaya, J., Rosenbalt, M., Belinsky, P. & Coleman, R. (1997) Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercertin or catechins, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arteriosler. Thromb. Vasc. Biol. 17: 2744-2752.
19. Wilcox, L. J., Borradaile, N. M., de Dreu, L. E. & Huff, M. W. (2001) Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J. Lipid Res. 42: 725-734.
20. Abu-Amsha Caccetta, R., Croft, K. D., Beilin, L. J. & Puddey, I. B. (2000) Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am. J. Clin. Nutr. 71: 67-74.
21. Lavy, A., Furhman, B., Markerl, A., Dankner, G., Amotz, A., Presser, D. & Aviram, M. (1994) Effect of dietary supplementation of red wine or white wine on human blood chemistry, hematology and coagulation. Ann. Nutr. Metab. 38: 287-294.
22. Sharpe, P. C., McGrath, E., Young, L. S. & Archbold, G.P.R. (1995) Effect of red wine consumption on lipoprotein (a) and other risk factors for atherosclerosis. Q. J. Med. 88: 101-108.
23. Struck, M., Watkins, T., Tomeo, A. & Halley, J. (1994) Effect of red and white wine on serum lipids, platelet aggregation, oxidation products and antioxidants: preliminary report. Nutr. Res. 14: 1811-1819.
24. Singleton, V. L., Joseph, A. & Rossi, J. R. (1965) Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am. J. Enol. Vitic. 16: 144-158.
25. Pal, S., Bottema, C.D.K. & Roach, P. D. (2002) The effect of dietary saturated and polyunsaturated fatty acids on the expression of the low density lipoprotein receptor gene. J. Nutr. Biochem. 13: 55-63.
26. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
27. Folch, J., Lees, M. & Sloane-Stanley, G. M. (1957) A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
28. Zilversmit, D. B. & Shea, T. M. (1989) Quantitation of apoB48 and apoB100 by gel scanning or radio-iodination. J. Lipid Res. 30: 1639-1646.
29. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidiniumthiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
30. Powell, E. E. & Kroon, P. A. (1992) Measurement of mRNA by quantitative PCR with a nonradioactive label. J. Lipid Res. 33: 609-614.
31. Mohammadi, A., Macri, J, Newton, R., Romain, T., Dulay, D. & Adeli, K. (1998) Effects of atorvastatin on intracellular stability and secretion of apolipoprotein B in HepG2 cells. Arterioscler. Thromb. Vasc. Biol. 18: 783-93.
32. 48 containing very low density lipoprotein in McArdle RH-7777 cells. J. Biol. Chem. 269: 25879-25888.
33. Brown, M. S. & Goldstein, J.L.A (1986) Receptor-mediated pathway for cholesterol homeostasis. Science (Washington, DC) 232: 34-47.
34. Brown, M. S. & Goldstein, J. L. (1998) Sterol regulatory element binding proteins (SREBPs): controllers of lipid synthesis and cellular uptake. Nutr. Rev. 56: S1-S3.
35. Pullinger, C. R., North, B. B., Teng, V. A., Rifici, A. & Scott, J. (1989) The apoprotein B gene is constituently expressed in HepG2 cells: regulation of secretion by oleic acid albumin and insulin and measurement of the mRNA half life. J. Lipid Res. 30: 1065-1077.
36. Furukawa, S., Sakata, N., Ginsberg, H. N. & Dixon, J. L. (1992) Studies of the sites of intracellular degradation of apolipoprotein B in HepG2 cells. J. Biol. Chem. 267: 22630-22638.
37. Cianflone, K. M., Yasruel, Z., Rodriguez, M. A., Vas, D. & Sniderman, A. D. (1990) Regulation of apoB secretion from HepG2 cells. Evidence for a critical role of cholesterol ester synthesis in the response to a fatty acid challenge. J. Lipid Res. 31: 2045-2055.
38. Tanaka, M., Jingami, H., Otani, M., Cho, M., Ueda, Y., Arai, H., Nagano, Y., Doi, T., Yokode, M. & Kita, T. (1993) Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesterol ester content in rabbit hepatocytes. J. Biol. Chem. 268: 12713-12718.
39. 100 in normolipidemic subjects. Am. J. Physiol. 273: E462-E470.
40. Burnett, J. R., Wilcox, L. J., Telford, D. E., Kleinstiver, S. J., Barrett, P. H. R., Newton, R. S. & Huff, M.W. (1997) Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. Arterioscler. Thromb. Vasc. Biol. 17: 2589-2600.
41. Borradaile, N. M., de Dreu, L. E., Wilcox, L. J., Edwards, J. Y. & Huff, M. W. (2002) Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem. J. 366: 531-539.
42. Borradaile, N. M., de Dreu, L. E., Barrett, H. & Huff, M. W. (2002) Inhibition of hepatocyte apoB secretion; enhanced rapid intracellular degradation independent of reduced microsomal cholesterol esters. J. Lipid Res. 43: 1544-1554.
43. Rudling, M. (1992) Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show a coordinate regulation in vivo. J. Lipid Res. 33: 493-501.
44. Bursell, C., Roach, P. D. & Pal, S. (2001) Green tea upregulates the low-density lipoprotein receptor through the sterol-regulated element binding protein in HepG2 liver cells. J. Agric. Food Chem. 49: 5639-5645.
45. Endo, A. (1992) The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33: 1569-1582.
46. Riceevans, C. A., Miller, N. J., Bolwell, P. G., Bramley, P. M. & Pridham, J. B. (1995) The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic. Res. 22: 375-383.
47. Abu-Amsha Caccetta, R., Croft, K. D., Beilin, L. J. & Puddey, I. B. (2000) Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am. J. Clin. Nutr. 71: 67-74.